KR101936294B1 - Composition comprising for skin-whitening and anti-wrinkling extract of Rumex acetosella L. or extract of Hydrangea serrata - Google Patents

Composition comprising for skin-whitening and anti-wrinkling extract of Rumex acetosella L. or extract of Hydrangea serrata Download PDF

Info

Publication number
KR101936294B1
KR101936294B1 KR1020160062854A KR20160062854A KR101936294B1 KR 101936294 B1 KR101936294 B1 KR 101936294B1 KR 1020160062854 A KR1020160062854 A KR 1020160062854A KR 20160062854 A KR20160062854 A KR 20160062854A KR 101936294 B1 KR101936294 B1 KR 101936294B1
Authority
KR
South Korea
Prior art keywords
composition
extract
skin
activity
present
Prior art date
Application number
KR1020160062854A
Other languages
Korean (ko)
Other versions
KR20170132388A (en
Inventor
김지형
이선희
Original Assignee
코스맥스바이오 주식회사
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 코스맥스바이오 주식회사 filed Critical 코스맥스바이오 주식회사
Priority to KR1020160062854A priority Critical patent/KR101936294B1/en
Publication of KR20170132388A publication Critical patent/KR20170132388A/en
Application granted granted Critical
Publication of KR101936294B1 publication Critical patent/KR101936294B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/02Preparations for care of the skin for chemically bleaching or whitening the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00Function of food ingredients
    • A23V2200/30Foods, ingredients or supplements having a functional effect on health
    • A23V2200/318Foods, ingredients or supplements having a functional effect on health having an effect on skin health and hair or coat

Abstract

본 발명은 애기수영 또는 산수국의 추출물을 유효성분으로 함유하는 주름개선 또는 피부 미백용 조성물에 관한 것이다.
본 발명에 따르면, 본 발명의 조성물은 티로시나아제 또는 엘라스타아제를 저해함으로써 피부 주름개선 또는 피부 미백효과를 나타낼 수 있으며, 안전한 소재로서 애기수영 또는 산수국의 추출물은 식품 조성물 분야 또는 화장품 분야에 유용하게 사용될 수 있다.
The present invention relates to a composition for improving wrinkles or for whitening skin, which contains an extract of Swine Swine or mountain juice as an active ingredient.
According to the present invention, the composition of the present invention can exhibit skin wrinkle improvement or skin whitening effect by inhibiting tyrosinase or elastase, and as a safe material, Can be usefully used.

Description

애기수영 또는 산수국의 추출물을 유효성분으로 함유하는 주름개선 또는 피부미백용 조성물{Composition comprising for skin-whitening and anti-wrinkling extract of Rumex acetosella L. or extract of Hydrangea serrata}[0001] The present invention relates to a composition for improving wrinkles or skin whitening comprising an extract of Rumex acetosella L. or extract of Hydrangea serrata,

본 발명은 주름개선 또는 피부 미백용 조성물에 관한 것으로, 더욱 구체적으로 애기수영 또는 산수국의 추출물을 유효성분으로 함유하는 주름개선 또는 피부 미백용 조성물에 관한 것이다.The present invention relates to a composition for improving wrinkles or skin whitening, and more particularly to a composition for improving wrinkles or skin whitening, which contains an extract of Aji swim or mountain water soup as an active ingredient.

노령인구가 증가함에 따라 노화의 척도가 될 수 있는 피부미용 및 노화를 방지할 수 있는 항산화 분야가 주요 관심사로 떠오르고 있다. 노화로 인한 피부의 주름생성 및 체내의 항산화 활성 감소 등은 건강의 척도로 사용될 수 있다. 피부노화는 요인에 따라 내인성 노화 (Intrinsic aging)와 외인성 노화 (Extrinsic aging)로 구분할 수 있다. 내인성 노화는 나이에 따른 피부 표피 및 진피의 생리적 기능 변화가 원인이며, 외인성 노화는 대기오염, 자외선 노출, 스트레스 등의 환경으로부터 발생하는 피부의 생리적 기능 변화가 원인으로 알려져 있다. 이러한 노화의 공통적 메커니즘은 산화적 스트레스 (Oxidative Stress)에 지속적으로 노출되어 체내의 자유라디칼(Free Radical)이 증가되고, 진피의 결합조직인 엘라스틴 (Elastin)을 분해하는 엘라스타제(Elastase)의 활성증가, 히아루론산 (Hyaluronic acid)을 분해는 히아루론라제(Hyaluronidase)의 활성 증가로 설명될 수 있다. 즉, 피부노화란 피부의 기본적 구조인 엘라스틴 및 히아루론산이 피괴되어 진피를 무너트리고 피부를 건조하게 만들어 주름이 생기는 것으로 설명될 수 있다. 또한, 체내의 라디칼은 멜라닌 형성과정에 관여하여 타이로시나아제(Tyrosinase)를 활성화시켜 기미와 주근깨를 생성하는 원인이 되기도 한다.As the elderly population increases, the beauty of the skin, which can be a measure of aging, and the antioxidant that can prevent aging are becoming a major concern. The generation of wrinkles of the skin due to aging and the reduction of antioxidant activity in the body can be used as a measure of health. Skin aging can be classified into intrinsic aging and extrinsic aging depending on factors. Endogenous aging is caused by changes in physiological functions of skin epidermis and dermis according to age. Exogenous aging is known to be caused by changes in physiological functions of skin caused by environmental pollution, exposure to ultraviolet rays, and stress. The common mechanism of this aging is to increase the free radicals in the body by continuously being exposed to oxidative stress and to increase the activity of Elastase which breaks down the connective tissue of the dermis, Elastin , Degradation of hyaluronic acid (Hyaluronic acid) can be explained by increased activity of hyaluronidase. In other words, skin aging can be explained by the collapse of elastin and hyaluronic acid which are basic structures of skin, collapsing the dermis, making skin dry, and wrinkles. In addition, radicals in the body are involved in the melanin formation process, thereby activating tyrosinase, which causes spots and freckles.

일상생활에서 우리는 활성산소에 의해 일어나는 유해성에 항상 노출되어 있으며, 노화로 인한 유해성은 점진적으로 축적되며 항산화 능력은 점진적으로 감소된다. 일반적인 신체 조건에서 항산화 보호 시스템은 효소(Superoxide dismutase 등) 반응과 비효소(Polyphenols, Flavonoids 등) 반응의 경로로 활성산소를 제거한다. 따라서 항산화 활성을 나타내기 위해서는 SOD와 같은 항산화 효소반응을 활성화 시키거나 직접적인 항산화 작용을 하는 비효소 물질을 섭취해야 한다.In everyday life, we are always exposed to the hazards caused by active oxygen, the aging hazards accumulate gradually, and the antioxidant capacity is gradually reduced. Under normal physical conditions, the antioxidant protection system removes reactive oxygen species through enzymatic (superoxide dismutase, etc.) and non-enzyme (polyphenols, flavonoids, etc.) pathways. Therefore, in order to exhibit antioxidant activity, it is necessary to activate the antioxidant enzyme reaction such as SOD or to take a non-enzyme substance which has a direct antioxidant effect.

이에 따른 피부건강 및 항산화에 대한 기전 연구가 활발히 진행되어 왔으며 생화학적 효능, 효과를 나타내는 화장료 및 건강기능식품에 대한 연구가 진행되고 있다. 연구수준의 발달 및 기술력 증가로 실질적인 효능, 효과를 가진 소재들이 주 연구 대상이다.Therefore, research on the mechanism of skin health and antioxidation has been actively conducted, and researches on cosmetics and health functional foods showing biochemical efficacy and efficacy have been conducted. The main research subjects are materials with practical effects and effects due to the development of research level and the increase of technology.

식물유래 소재는 안전성 측면에서 우수하여 오랫동안 이용되었으며, 특히 국내의 경우, 민간에서 이용되거나 혹은 한방에서 이용되는 식물 및 생약성분을 주로 한 기능성 소재 개발이 활발히 이루어지고 있다.Plant-derived materials have been used for a long time because of their excellent safety, and in particular, functional materials based on plant and herbal ingredients used in the private sector or used in oriental medicine are actively developed.

산수국(Hydrangea serrata)은 범의귀과의 넓은 잎 작은 키 나무로 식약처에서 고시한 식품원재료에 잎 부위가 식용가능부위로 명시되어 있다. 한방에서는 생약명으로 칠엽담이라고 하여 만성기관지염, 지해, 거담, 소염해독 등의 치료에 예로부터 사용되고 있다. 한국공개특허 제2004-0063874호에서는 고혈당 및 고지혈증 억제 활성을 갖는 감차수국 추출물을 함유한 조성물이 개시되었다. Hydrangea serrata is a broad-leaved tall tree of the submandibular gland, and its leaf parts are indicated as edible parts in food raw materials notified in the place of shipment. It is used as a treatment for chronic bronchitis, warts, genomes, and anti-inflammatory drugs. Korean Patent Laid-Open Publication No. 2004-0063874 discloses a composition containing an extract of Oncorhynchospora having hyperglycemia and hyperlipemia inhibitory activity.

애기수영 (Rumex acetosella L.)은 마디풀과에 속하는 식물로 식약처에서 고시한 식품원재료에 어린잎이 식용가능부위로 명시되어 있으며, 한방에서는 잎과 줄기를 약재로 쓰며 주로 항암, 항산화, 이뇨제 및 혈제, 폐결핵 치료에 효과가 있다고 알려져 있다(약초의 성분과 이용, 일월서각. 1994). 한국공개특허 제2005-0056569호에서는 애기수영의 항염, 항산화, 항균작용 기반의 아토피 피부 개선 효과 화장품이 개시되었다.Swim swimming ( Rumex Acetosella L. ) is a plant belonging to the genus Pseudomonas spp., which is indicated as a possible food source in the raw materials of foodstuffs notified by the pet food. The leaves and stems of the leaves are used as medicinal materials and mainly used for anticancer, antioxidant, diuretic, (Use of herbal ingredients and use, Jan., 1994). Korean Patent Laid-Open Publication No. 2005-0056569 discloses a cosmetic for improving atopic skin based on anti-inflammatory, antioxidant, and antibacterial action of swine swimming.

그러나, 애기수영 또는 산수국의 피부 주름개선 또는 피부 미백효과에 대한 직접적인 기전 연구가 이루어지지 않은 실정이다. 따라서 본 발명자들은 상기 추출물들이 가지는 피부 주름 또는 피부 미백에 대한 직접적인 기초 효능 연구를 수행하였다.However, there is no direct research on the mechanism of skin wrinkle improvement or skin whitening effect in swine swimming or mountain sowing. Therefore, the inventors of the present invention conducted a study on the direct basic effects of the extracts on skin wrinkles or skin whitening.

이에, 본 발명자들은 상기 종래기술들의 문제점들을 극복하기 위하여 예의 연구노력한 결과, 애기수영(Rumex acetosella L.) 또는 산수국(Hydrangea serrata)의 추출물을 유효성분으로 함유하는 주름개선 또는 피부 미백용 조성물의 경우, 티로시나아제 또는 엘라스타아제를 저해함으로써 피부 주름개선 또는 피부 미백효과를 나타낼 수 있음을 확인하고, 본 발명을 완성하게 되었다.Thus, the present inventors have made research efforts result, baby swim (Rumex to overcome the problems of the prior art acetosella L. ) or hydrangea serrata as an active ingredient, it may exhibit skin wrinkle improvement or skin whitening effect by inhibiting tyrosinase or elastase. And the present invention was completed.

KRKR 10-2004-006387410-2004-0063874 AA KRKR 10-2005-005656910-2005-0056569 AA

WOO, M. S., et al. Comparison of skin elasticity test results from the Ballistometer® and Cutometer®. Skin Research and Technology, 2014, 20.4: 422-428. WOO, M. S., et al. Comparison of skin elasticity test results from the Ballistometer® and Cutometer®. Skin Research and Technology, 2014, 20.4: 422-428. IMOKAWA, Genji. Mechanism of UVB-induced wrinkling of the skin: paracrine cytokine linkage between keratinocytes and fibroblasts leading to the stimulation of elastase. In: Journal of Investigative Dermatology Symposium Proceedings. Nature Publishing Group, 2009. p. 36-43. IMOKAWA, Genji. Mechanism of UVB-induced wrinkling of the skin: paracrine cytokine linkage between keratinocytes and fibroblasts leading to the stimulation of elastase. In: Journal of Investigative Dermatology Symposium Proceedings. Nature Publishing Group, 2009. p. 36-43.

따라서, 본 발명의 주된 목적은 엘라스타아제 또는 티로시나아제를 저해함으로써 피부 주름개선 또는 피부 미백효과를 갖는 애기수영 또는 산수국의 추출물을 유효성분으로 함유하는 주름개선 또는 피부미백용 조성물을 제공하는 데 있다.Accordingly, it is a main object of the present invention to provide a composition for improving wrinkles or skin whitening comprising an effective amount of an extract of a swine swimming or mountainous soup having skin wrinkle improvement or skin whitening effect by inhibiting elastase or tyrosinase There is.

본 발명의 한 양태에 따르면, 본 발명은 애기수영(Rumex acetosella L.) 또는 산수국(Hydrangea serrata)의 추출물을 유효성분으로 함유하는 주름개선 또는 피부미백용 조성물을 제공한다.According to one aspect of the invention there is provided a baby swim (Rumex acetosella L. ) or an extract of Hydrangea serrata as an active ingredient.

노령인구가 증가함에 따라 노화의 척도가 될 수 있는 피부미용이 주요 관심사로 떠오르고 있다. 피부 미용 중에서도 특히, 주름개선과 피부 미백에 대한 관심이 꾸준히 증가하고 있으며, 이를 개선하기 위하여 많은 건강기능식품과 화장품들의 연구가 활발히 진행되고 있을 뿐만 아니라 이들의 제품이 다양하게 출시되고 있다. 그러나 건강기능식품과 화장품은 직접적으로 섭취하고 피부에 흡수시키는 만큼 안전성 또한 중요한 문제이기 때문에 안전성 측면에서 우수한 식물유래 소재는 꾸준히 이용되고 있다. 이에, 본 발명자들은 천연식물유래 소재 중 애기수영 추출물 또는 산수국 추출물이 피부 주름개선 또는 피부미백 효과가 우수하다는 것을 확인하고 본 발명을 완성하게 되었다.As the elderly population increases, the beauty of the skin, which can be a measure of aging, is becoming a major concern. In particular, the interest in wrinkle improvement and skin whitening has been increasing steadily, and many health functional foods and cosmetics have been actively researched in order to improve them, and their products are being widely launched. However, since health functional foods and cosmetics are directly ingested and absorbed into the skin, safety is also an important issue. Therefore, plant-derived materials superior in safety are being steadily used. Accordingly, the inventors of the present invention have confirmed that the baby swim extract or the mountain water extract of the natural plant-derived material is excellent in skin wrinkle improvement or skin whitening effect, and the present invention has been completed.

본 발명에 있어서, 상기 추출물은 종래에 천연식물을 추출하기 위하여 이용된 어떠한 용매로로 추출될 수 있으며, 바람직하게는 물, 발효주정 또는 이들의 혼합용매로, 더욱 바람직하게는 에탄올로 추출되는 것을 특징으로 한다.In the present invention, the extract can be extracted with any solvent conventionally used for extracting natural plants, preferably water, fermented juice or a mixed solvent thereof, more preferably extracted with ethanol .

본 발명에 있어서, 상기 조성물은 조성물 총 중량대비 0.001 내지 80.0 중량%로 포함할 수 있으며, 바람직하게는 5 내지 20 중량% 포함하는 것을 특징으로 한다. 또한 상기 조건에서 높은 수율과 뛰어난 효소억제 효능을 나타냄을 확인할 수 있었다.In the present invention, the composition may be contained in an amount of 0.001 to 80.0% by weight, and preferably 5 to 20% by weight based on the total weight of the composition. Also, it was confirmed that the above conditions exhibited a high yield and excellent enzyme inhibitory effect.

본 발명에 있어서, 상기 조성물은 엘라스타아제(Elastase)를 저해함으로써 주름개선 효과를 나타내는 것을 특징으로 한다.In the present invention, the composition is characterized by exhibiting an effect of improving wrinkles by inhibiting elastase.

본 발명의 실험예에 따르면, 본 발명의 애기수영 추출물 또는 산수국 추출물의 경우 엘라스타아제 활성 저해율이 양성대조군인 아데노신(Adempsin)과 유사한 범위의 효과를 나타내는 것을 확인하였으며, 본원발명의 조성물이 단일물질이 아닌 추출물이라는 점을 감안할 때, 그 수치는 결코 낮은 것이 아님을 확인할 수 있었다. 이러한 결과로 볼 때, 본원발명의 조성물은 진피의 결합조직인 엘라스틴을 분해하는 엘라스타아제를 저해함으로써, 피부의 주름이 생기는 것을 개선할 수 있음을 알 수 있다(실험예 2 참조).According to the experimental examples of the present invention, it was confirmed that the inhibition rate of the elastase activity in the case of the baby swimming extract or the extract of the acidophilus extract of the present invention showed a similar effect to that of the positive control adempsin (Adempsin) Given that it is an extract that is not a substance, we can confirm that the figure is never low. From these results, it can be seen that the composition of the present invention can improve the appearance of wrinkles of the skin by inhibiting elastase which degrades elastin, which is a connective tissue of dermis (see Experimental Example 2).

본 발명에 있어서, 상기 조성물은 티로시나아제(Tyrosinase)를 저해함으로써 피부미백 효과를 나타내는 것을 특징으로 한다.In the present invention, the composition is characterized by exhibiting skin whitening effect by inhibiting tyrosinase.

본 발명의 실험예에 따르면, 본 발명의 애기수영 추출물 또는 산수국 추출물의 경우 티로시나아제 활성 저해율이 양성대조군인 알부틴(Arbutin)과 유사한 범위의 효과를 나타내는 것을 확인하였으며, 본원발명의 조성물이 단일물질이 아닌 추출물이라는 점을 감안할 때, 그 수치는 결코 낮은 것이 아님을 확인할 수 있었다.이러한 결과로 볼 때, 본원발명은 조성물은 색소침착을 유발하는 멜라닌 생성 과정에 관여하는 효소인 티로시나아제의 활성을 저해함으로써, 피부 미백효과를 나타낼 수 있음을 알 수 있다(실험예 1 참조).According to the experimental examples of the present invention, it was confirmed that the inhibitory activity of tyrosinase activity in the case of the Ajiwa swimming extract or the extract of Sansho sprout of the present invention showed a similar effect to that of Arbutin, which is a positive control group, In view of these facts, the present invention relates to a composition for inhibiting melanin production, which is an enzyme involved in the production of melanin, which causes pigmentation, of tyrosinase It is possible to show a skin whitening effect by inhibiting the activity (see Experimental Example 1).

본 발명에 있어서, 상기 조성물은 정제, 과립제, 환제, 캡슐제, 액상형, 젤리 또는 껌으로 구성되는 군으로부터 선택된 하나 이상의 제형을 갖는 것으로서, 구강 섭취용 인 것을 특징으로 한다.In the present invention, the composition has at least one form selected from the group consisting of tablets, granules, pills, capsules, liquids, jellies or gums, and is characterized in that it is for oral consumption.

본 발명에 있어서, 상기 조성물은 유연화장수, 영양 화장수, 영양 크림, 수분 크림, 스팟, 젤 로션 또는 연고로 구성된 군으로부터 선택된 하나 이상의 제형을 갖는 것으로서, 피부 외용제용 인 것을 특징으로 한다.In the present invention, the composition has at least one formulation selected from the group consisting of a softening agent, a nutritional lotion, a nutritional cream, a water cream, a spot, a gel lotion or an ointment.

이상 설명한 바와 같이, 본원발명의 애기수영 추출물 또는 산수국 추출물을 함유하는 조성물은 엘라스타아제(Elastase), 티로시나아제 (Tyrosinase) 효소를 저해함으로써 피부 주름 개선 또는 피부 미백효과를 나타내어 피부 미용을 위한 조성물로 적합하며, 안전한 소재로서 애기수영 또는 산수국의 추출물을 식품 조성물 분야 또는 화장품 분야에 유용하게 사용될 수 있다.As described above, the composition of the present invention containing the baby swimming extract or the extract of mountain juice extract inhibits elastase and tyrosinase, thereby exhibiting skin wrinkle improvement or skin whitening effect, Composition, and as a safe material, an extract of Swine Swine or Mountain Swine can be usefully used in the fields of food composition or cosmetics.

이하, 실시예를 통하여 본 발명을 더욱 상세히 설명하기로 한다. 이들 실시예는 단지 본 발명을 예시하기 위한 것이므로, 본 발명의 범위가 이들 실시예에 의해 제한되는 것으로 해석되지는 않는다.Hereinafter, the present invention will be described in more detail with reference to Examples. These embodiments are only for illustrating the present invention, and thus the scope of the present invention is not construed as being limited by these embodiments.

실시예 1: 에탄올을 이용한 추출물의 제조Example 1: Preparation of an extract using ethanol

본 발병의 조성물에 함유되는 애기수영 및 산수국의 추출물은 다음과 같은 과정에 의해 제조된다. 우선, 제주도 내에서 자생하는 1년생 애기수영 및 산수국을 구입하여 증류수로 깨끗이 씻은 다음, 햇빛이 없는 서늘한 곳에서 중량의 변화가 없을 때까지 완전히 건조시켰다. 그 후, 완전히 건조된 건조물을 균질화기를 사용하여 분쇄하여 분쇄물들을 얻은 다음 에탄올 : 증류수를 7 : 3의 중량비로 혼합하여 추출 용매 400g 씩을 준비 한 후, 상기 분쇄물을 각각 50g 씩 첨가하였다. 이때, 분쇄물과 추출용매의 혼합비율은, 중량비로 1 : 8로 하였다. 다음으로, 상기 분쇄물과 혼합한 추출 용매를 진탕 항온 수조에 넣어서 50 ℃, 2시간 동안 교반추출 하였다. 추출에 의해 얻어진 물질은 상온에서 와트만(No 2.) 추출 용매 여과지를 사용하여 불용성 물질을 제거하였다. 그 후, 냉각 콘덴서가 달린 증류장치에서 감압농축 하면서 용매를 완전히 제거하였다. 추출물을 완전히 건조 후 각각의 수율을 측정하였다. 각각의 수율 측정 결과 애기수영은 5.82%, 산수국은 20%를 나타내었다.The baby swim and the extract of the mountaineering soup contained in the composition of the present invention are produced by the following process. First of all, the first year baby swimming and mountain juice native to Jeju Island was purchased, washed thoroughly with distilled water, and completely dried until there was no change in weight in a cool, sun-free place. Thereafter, the completely dried dried material was pulverized by using a homogenizer to obtain pulverized products, and 400 g of an extraction solvent was prepared by mixing ethanol and distilled water at a weight ratio of 7: 3, and then 50 g of each of the pulverized products was added. At this time, the mixing ratio of the pulverized material to the extraction solvent was 1: 8 by weight. Next, the extraction solvent mixed with the pulverized product was put into a shaking constant-temperature water bath and stirred at 50 DEG C for 2 hours. The material obtained by extraction was insoluble matter removed at room temperature using Wattman (No. 2) extraction solvent filter paper. Thereafter, the solvent was completely removed while concentrating under reduced pressure in a distillation apparatus equipped with a cooling condenser. The extracts were completely dried and their yields were measured. As a result of the measurement of yield, the swimming rate was 5.82% and the mountain water station was 20%.

실험예 1: 티로시나아제 활성 저해 효과Experimental Example 1: Inhibition of tyrosinase activity

상기 실시예 1에서 얻은 추출물에 대하여 티로시나아제 활성 저해 효과를 측정하였다. 본 실험에서 티로시나아제는 버섯류로부터 추출한 것을 사용하였다 (Sigma-Aldrich, US). 티로시나아제에 기질인 L-티로신 기질의 멜라닌 형성에 근거하여 발색되는 정도를 490nm에서 흡광수치를 측정하는 실험법을 사용하였다. The inhibitory effect of tyrosinase activity on the extract obtained in Example 1 was measured. In this experiment, tyrosinase was extracted from mushrooms (Sigma-Aldrich, US). The degree of color development based on melanin formation of the L-tyrosine substrate, which is a substrate for tyrosinase, was determined by measuring the absorbance at 490 nm.

0.1M 인산 완충용액(Phosphate buffer pH 6.8) 120㎕에 1.5mM L-티로신 40㎕를 넣어 반응용액을 만들었다. 반응용액에 시료액을 20㎕씩 첨가하고 5분간 안정화 시킨 후, 머쉬룸 티로시나제 (100 U/㎖)를 20㎕ 첨가하여 37 ℃에서 10분간 효소반응 시켰다. 대조군에는 시료액 대신 DMSO를 넣었으며, 공시료액에는 시료액 대신 DMSO 및 효소대신 0.1M 인산 완충용액을 첨가하였다. 반응용액을 모두 첨가하여 37 ℃에서 10분간 효소반응 시킨 후, 490nm에서 흡광도를 측정하고 하기 수학식 1에 따라 계산하여 시료의 효소저해활성 정도를 구하였다. 그 결과는 표 1에 나타내었다.To 120 μl of 0.1 M phosphate buffer (Phosphate buffer pH 6.8), 40 μl of 1.5 mM L-tyrosine was added to prepare a reaction solution. After adding 20 μl of the sample solution to the reaction solution and stabilizing for 5 minutes, 20 μl of mushroom tyrosinase (100 U / ml) was added and enzyme reaction was performed at 37 ° C for 10 minutes. In the control group, DMSO was added instead of the sample solution. DMSO and 0.1 M phosphate buffer solution were added to the blank sample instead of the sample solution. The reaction solution was added, and the reaction was allowed to proceed at 37 ° C for 10 minutes. The absorbance at 490 nm was measured and calculated according to the following equation (1) to determine the enzyme inhibitory activity of the sample. The results are shown in Table 1.

[식 1][Formula 1]

Figure 112016049272252-pat00001
Figure 112016049272252-pat00001

추출물extract 티로시나아제 활성 저해율 (%)Inhibition rate of tyrosinase activity (%) 200㎍/㎖200 [mu] g / ml 100㎍/㎖100 mu g / ml 50㎍/㎖ 50 mu g / ml 산수국Mountain landscape 21.8621.86 10.3510.35 5.175.17 애기수영Baby swimming 24.5024.50 18.3718.37 9.199.19 알부틴Arbutin 29.5029.50 21.3021.30 10.2010.20

상기 표 1의 결과와 같이, 산수국 및 애기수영의 추출물을 농도별로 처리하여 티로시나아제 활성저해 실험을 수행한 결과, 양성대조군인 알부틴과 유사한 범위의 효과를 나타내는 것을 확인하였으며, 본원발명의 조성물이 추출물임을 감안할 때 농도 의존적으로 비교적 높은 티로시나아제 활성저해 효능을 확인할 수 있었다. 또한 애기수영이 산수국보다 더 높은 활성저해 효과를 보임으로, 피부 미백에 더 효과적인 조성물로 사용될 수 있음을 확인하였다.As shown in the above Table 1, the tyrosinase activity inhibition test was carried out by treating the extract of Araliae sativa L. and Swine Swine by concentration, and it was confirmed that the effect was similar to that of arbutin, which is a positive control group. Considering this extract, the tyrosinase activity inhibitory effect was relatively high in a concentration-dependent manner. In addition, it has been confirmed that swine swimming can be used as a more effective composition for skin whitening because it exhibits a higher activity inhibitory effect than that of mountain syrup.

실험예 2: 엘라스타아제 활성 저해 효과Experimental Example 2: Elastase activity inhibitory effect

상기 실시예 1에서 얻은 추출물에 대하여 엘라스타아제 활성 저해 효과를 측정하였다. 본 실험에서 엘라스타아제는 돼지췌장으로부터 추출한 것을 사용하였다 (Sigma-Aldrich, US). 엘라스타아제에 펩티드 기질인 N-석시닐-(Ala)3-p-니트로아닐린의 가수분해를 통해 단위시간당 생성되는 4-니트로아닐린의 방출량의 증가를 엘라스타아제의 활성치로 측정하는 실험법을 사용하였다. The extract obtained in Example 1 was measured for the inhibitory effect of elastase activity. Elastase was extracted from the pig pancreas in this experiment (Sigma-Aldrich, US). N-succinyl- (Ala) 3-p-nitroaniline, which is a peptide substrate of elastase, is used to measure the increase in the amount of 4-nitroaniline produced per unit time by the activity of the elastase Respectively.

0.276 M Trizma-HCl (pH 8.0) 140㎕에 8.8 mM N-석시닐-(Ala)3-p-니트로아닐린을 20㎕ 넣어 반응용액을 만들었다. 반응용액에 시료액을 20㎕씩 첨가하고 5분간 안정화 시킨 후, 엘라스타아제 (2.5 U/㎖)를 20㎕ 첨가하여 37 ℃에서 20분간 효소반응 시켰다. 대조군에는 시료액 대신 DMSO를 넣었으며, 공시료액에는 시료액 대신 DMSO 및 효소대신 BSA용액을 첨가하였다. 반응 후 410㎚에서 흡광도를 측정하였으며, 결과를 하기 수학식 2에 따라 계산하여 시료의 효소저해활성 정도를 구하였다. 그 결과는 표 2에 나타내었다.20 μl of 8.8 mM N-succinyl- (Ala) 3-p-nitroaniline was added to 140 μl of 0.276 M Trizma-HCl (pH 8.0) to prepare a reaction solution. 20 μl of the sample solution was added to the reaction solution, and after stabilization for 5 minutes, 20 μl of elastase (2.5 U / ml) was added and enzyme reaction was carried out at 37 ° C for 20 minutes. In the control group, DMSO was added instead of the sample solution. DMSO was used instead of the sample solution and BSA solution was added to the blank solution instead of the enzyme. After the reaction, the absorbance was measured at 410 nm, and the result was calculated according to the following equation (2) to determine the enzyme inhibition activity of the sample. The results are shown in Table 2.

[식 2][Formula 2]

Figure 112016049272252-pat00002
Figure 112016049272252-pat00002

추출물extract 엘라스타아제 활성 저해율 (%)Elastase activity inhibition (%) 200㎍/㎖200 [mu] g / ml 100㎍/㎖100 mu g / ml 50㎍/㎖50 mu g / ml 산수국Mountain landscape 11.5711.57 11.0111.01 6.076.07 애기수영Baby swimming 9.389.38 7.857.85 7.157.15 아데노신Adenosine 18.40 18.40 17.36 17.36 11.14 11.14

상기 표 2의 결과와 같이, 산수국 및 애기수영의 추출물을 농도별로 처리하여 엘라스타아제 활성저해 실험을 수행한 결과, 양성대조군인 아데노신과 유사한 범위의 효과를 나타내는 것을 확인하였으며, 본원발명의 조성물이 추출물임을 감안할 때 농도 의존적으로 비교적 높은 엘라스타아제 활성저해 효능을 확인할 수 있었다. 또한 산수국이 애기수영보다 더 높은 활성저해 효과를 보임으로, 주름생성 억제에 더 효과적인 조성물로 사용될 수 있음을 확인하였다.As shown in the results of Table 2, the extract of Araliaceae and Aigi Swim was treated by concentration to examine the activity of inhibiting elastase activity. As a result, it was confirmed that the effect was similar to that of adenosine, which is a positive control, Considering this extract, the efficacy of inhibiting elastase activity, which is relatively high in concentration, could be confirmed. In addition, it was confirmed that the mountaineering plant showed a higher activity inhibitory effect than the baby swimming, and thus it can be used as a composition more effective in inhibiting wrinkle formation.

실험예 3: SOD 활성 효과Experimental Example 3: SOD activity effect

상기 실시예 1에서 얻은 추출물에 대하여 SOD 효소 활성 효과를 측정하였다. 본 실험에서 과산화물제거효소(SOD, Superoxide dismutase) 활성 측정은 SOD Assay 키트를 구매하여 실시하였다(Sigma-Aldrich, US). 산화과정을 통해 생긴 과산화물에 의해 발색하는 WST-포마잔(WST-Formazan)을 420㎚에서 흡광수치를 측정한다. SOD 효소가 활성을 나타낼 때 과산화물이 감소하게 되고 포마잔의 생성이 감소함으로 인해 감소하는 발색정도를 측정해 효소 활성을 구하였다. The SOD enzyme activity of the extract obtained in Example 1 was measured. In this experiment, SOD and Superoxide dismutase activities were measured by SOD Assay Kit (Sigma-Aldrich, US). The WST-Formazan (WST-Formazan), which is developed by the peroxide generated by the oxidation process, is measured at 420 nm. The enzymatic activities of SOD enzymes were determined by measuring the degree of color degradation due to the decrease in peroxides and the decrease in formation of formazan when the enzyme showed activity.

키트의 WST 반응용액 160㎕에 시료액을 20㎕를 첨가하고 5분간 안정화 시킨 후, 효소반응용액을 20㎕ 첨가하여 37 ℃에서 30분간 효소반응 시켰다. 대조군에는 시료액 대신 DMSO를 넣었으며, 공시료액에는 시료액 대신 DMSO 및 효소대신 버퍼를 첨가하였다. 반응 후 420㎚에서 흡광도를 측정하였으며, 결과를 하기 수학식 3에 따라 계산하여 시료의 효소 활성 정도를 구하였다. 그 결과는 표 3에 나타내었다.Twenty microliters of the sample solution was added to 160 占 퐇 of the WST reaction solution of the kit, and after stabilization for 5 minutes, 20 占 퐇 of the enzyme reaction solution was added and the enzyme reaction was carried out at 37 占 폚 for 30 minutes. In the control group, DMSO was added instead of the sample solution. DMSO and buffer instead of enzyme were added to the blank sample instead of the sample solution. The absorbance was measured at 420 nm after the reaction, and the result was calculated according to the following equation (3) to determine the degree of enzyme activity of the sample. The results are shown in Table 3.

[식 3][Formula 3]

Figure 112016049272252-pat00003
Figure 112016049272252-pat00003

추출물extract SOD 효소 활성 (%)SOD enzyme activity (%) 200 μg/ml200 μg / ml 100 μg/ml100 μg / ml 50 μg/ml 50 μg / ml 산수국Mountain landscape 97.6497.64 90.4590.45 75.9875.98 애기수영Baby swimming 98.4498.44 94.8794.87 90.5190.51

상기 표 3의 결과와 같이, 산수국 및 애기수영의 추출물을 농도별로 처리하여 SOD 효소활성 실험을 수행한 결과, 산수국 및 애기수영의 SOD효소 활성 효능을 확인할 수 있었다. 키트를 사용하여 실험한 결과로, 추출물을 처리하지 않은 대조군 대비 농도 의존적으로 높은 SOD 효소 활성 효과를 나타냄을 확인하였다. 애기수영이 산수국보다 더 높은 SOD 활성 효과를 보였으며, 이는 낮은 처리 농도 (50㎍/㎖)에서도 90% 가까이 SOD 효소를 활성화시킴으로, 효과적인 항산화 조성물로 사용될 수 있음을 확인하였다.As shown in the above Table 3, SOD enzymatic activity tests were conducted on the extracts of mountain and southern flounder and swine swimming, and the activity of SOD enzymes was confirmed by SOD and swimming. As a result of the experiment using the kit, it was confirmed that the SOD enzyme activity was highly dependent on the concentration of the extract-treated control group. It was confirmed that swine swimming showed higher SOD activity effect than that of mountain syrup, and it can be used as an effective antioxidant composition by activating SOD enzyme at 90% at low treatment concentration (50 μg / ml).

실험예 4: 총 폴리페놀 함량 분석Experimental Example 4: Analysis of total polyphenol content

10㎎/㎖의 농도로 용해한 추출물 20㎕에 20% 폴린-시오칼토(Folin Ciocalteau)시약을 10 % 탄산 나트륨(Na2CO3)용액을 섞어 140㎕ 및 dH2O 20㎕를 차례로 가하여 상온에서 30분간 반응시킨 후 765㎚에서 흡광도를 측정하였으며, 결과를 하기 수학식 4에 따라 계산하여 시료안의 폴리페놀 함량을 구하였다. 총 폴리페놀 함량은 갈릭산(Gallic Acid)을 표준물질로 정하여 시료와 동일한 방법으로 분석하여 작성한 검량 선으로부터 계산하였다. 그 결과는 표 4에 나타내었다.To 20 μl of the extract dissolved at a concentration of 10 mg / ml were added 140 μl of 20% Folin Ciocalteau reagent and 10% sodium carbonate (Na 2 CO 3 ) solution, and 20 μl of dH 2 O were added in order, After 30 minutes of reaction, the absorbance was measured at 765 nm. The polyphenol content in the sample was calculated by the following formula (4). The total polyphenol content was calculated from the calibration curve prepared by analyzing Gallic Acid in the same manner as the standard material. The results are shown in Table 4.

[식 4][Formula 4]

Figure 112016049272252-pat00004
Figure 112016049272252-pat00004

실험예 5: 총 플라보노이드 함량 분석Experimental Example 5: Analysis of total flavonoid content

10mg/ml의 농도로 용해한 추출물 20㎕에 5% 아질산나트륨 용액(NaNO2) 10㎕를 혼합하여 5분간 반응시키고 염화알루미늄 용액 (AlCl36H2O) 100㎕를 첨가하여 다시 5분간 반응시킨다. 그 후, 1M 수산화나트륨 (NaOH) 50㎕와 섞어 10분간 반응시킨 후 510㎚에서 흡광도를 측정하였으며, 결과를 하기 수학식 5에 따라 계산하여 시료안의 플라보노이드 함량을 구하였다. 총 플라보노이드 함량은 카테킨 (Catechin)을 표준물질로 정하여 시료와 동일한 방법으로 분석하여 작성한 검량 선으로부터 계산하였다. 그 결과는 표 4에 나타내었다.10 μl of 5% sodium nitrite solution (NaNO 2 ) was added to 20 μl of the extract dissolved at a concentration of 10 mg / ml, reacted for 5 minutes, added with 100 μl of aluminum chloride solution (AlCl 36 H 2 O) and reacted again for 5 minutes. Thereafter, 50 μl of 1 M sodium hydroxide (NaOH) was mixed and reacted for 10 minutes, and the absorbance was measured at 510 nm. The content of flavonoid in the sample was calculated by the following formula (5). The total flavonoid content was calculated from the calibration curve prepared by analyzing catechin (catechin) in the same manner as the standard material. The results are shown in Table 4.

[식 5][Formula 5]

Figure 112016049272252-pat00005
Figure 112016049272252-pat00005

추출물extract 총 폴리페놀 함량Total polyphenol content 총 플라보노이드 함량Total flavonoid content TPC (mgGAE/g)TPC (mg GAE / g) TFC (mgCathechin/g)TFC (mg Cathechin / g) 산수국Mountain landscape 5.595.59 5.385.38 애기수영Baby swimming 7.417.41 10.0010.00

제형예 1: 정제의 제조Formulation Example 1: Preparation of tablets

상기 실시예 1에서 얻은 추출물에 대하여 통상의 정제 제조방법에 따라 하기 표 5의 성분을 혼합하고 타정하여 정제를 제조한다.The extracts obtained in Example 1 were mixed with the components shown in Table 5 according to a conventional tablet preparation method and tableted to prepare tablets.

원료명Raw material name 단위중량Unit weight (mg) (mg) 실시예 1의 추출물The extract of Example 1 50 50 옥수수 전분Corn starch 100 100 유당Lactose 100100 스테아린산Stearic acid 22

제형예Formulation Example 2: 캡슐제의 제조 2: Preparation of capsules

상기 실시예 1에서 얻은 추출물에 대하여 통상의 캡슐제 제조방법에 따라 하기 표 6의 성분을 혼합하고 젤라틴 캡슐에 충전하여 캡슐제를 제조한다.The ingredients obtained in Example 1 were mixed with the ingredients shown in Table 6 according to a conventional capsule preparation method and filled in gelatin capsules to prepare capsules.

원료명Raw material name 단위중량Unit weight (mg) (mg) 실시예 1의 추출물The extract of Example 1 50 50 옥수수 전분Corn starch 100 100 유당Lactose 100100 스테아린산Stearic acid 22

제형예Formulation Example 3:  3: 액제의Liquid 제조 Produce

상기 실시예 1에서 얻은 추출물에 대하여 기호에 적합한 음료 제조방법에 따라서 하기 표 7의 성분을 혼합하고 과병 또는 파우치에 충전하여 액제를 제조한다.The ingredients obtained in Example 1 were mixed with the ingredients listed in Table 7 according to the preferred beverage preparation method, and filled into bottles or pouches to prepare a liquid preparation.

원료명Raw material name 단위중량Unit weight (g) (g) 실시예 1의 추출물The extract of Example 1 2.5050 2.5050 산탄검Xanthan gum 0.0075 0.0075 프락토올리고당액Fructooligosaccharide solution 0.7500 0.7500 코코넛꽃진액분말Coconut flower essence powder 1.0500 1.0500 쌍화농축액Twin condensate 1.5000 1.5000 홍삼향Red ginseng 0.0450 0.0450 정제수Purified water 9.1425 9.1425

제형예 4: 젤리의 제조Formulation Example 4: Preparation of jelly

상기 실시예 1에서 얻은 추출물에 대하여 기호에 적합한 젤리 제조방법에 따라서 하기 표 8의 성분을 혼합하고 삼면포에 충전하여 젤리를 제조한다.The extracts obtained in Example 1 were mixed with the ingredients shown in Table 8 according to the preferred jelly preparation method, and the jellies were prepared by filling three kinds of jelly.

원료명Raw material name 단위중량Unit weight (g) (g) 실시예 1의 추출물The extract of Example 1 2.0000 2.0000 푸드겔Food gel 0.3600 0.3600 카라기난Carrageenan 0.0600 0.0600 젖산칼슘Calcium lactate 0.1000 0.1000 구연산나트륨Sodium citrate 0.0600 0.0600 복합황금추출물Composite Golden Extract 0.0200 0.0200 효소처리스테비아Enzyme treatment Stevia 0.0440 0.0440 프락토올리고당액Fructooligosaccharide solution 5.0000 5.0000 적포도농축액Red grape concentrate 2.4000 2.4000 정제수Purified water 13.9560 13.9560

제형예 5 : 영양크림의 제조Formulation Example 5: Preparation of nutritional cream

상기 실시예 1에서 얻은 추출물에 대하여 영양크림을 통상의 방법에 따라 하기 표 9의 조성으로 제조하였다.Nutritive creams were prepared for the extracts obtained in Example 1 according to the usual methods according to the composition shown in Table 9 below.

원 료Raw material 함 량content 실시예 1의 추출물The extract of Example 1 1.01.0 시토 스테롤Sitosterol 4.04.0 폴리글리세릴 2-올레이트 3.0Polyglyceryl 2-olate 3.0 3.03.0 세테아레스-4Setares-4 2.02.0 콜레스테롤cholesterol 3.03.0 디세틸포스페이트Dicetyl phosphate 0.40.4 농글리세린Concentrated glycerin 5.05.0 선플라우어오일Sunflower oil 22.022.0 카르복시비닐폴리머Carboxyvinyl polymer 0.50.5 트리에탄올아민Triethanolamine 0.50.5 방부제antiseptic 미량a very small amount 향료Spices 미량a very small amount 정제수Purified water 잔량Balance

상기 제형예들의 실시예 1은 애기수영 추출물, 산수국 추출물, 또는 이들의 혼합 추출물에서 선택되는 어느 것 일 수 있다.Example 1 of the above formulation examples may be any one selected from a baby swimming extract, a mountain juice extract, or a mixed extract thereof.

또한, 상기의 조성비는 일반적으로 적합한 성분을 혼합하여 제형예로 조성하였지만, 필요에 따라서 그 배합비 및 원료를 임의로 변경 실시하여도 무방하다. In addition, although the above-mentioned composition ratio is generally prepared by mixing a suitable component, it is also possible to arbitrarily change the compounding ratio and the raw material as necessary.

본 발명의 추출물은 모든 제형예 시험 조건에서 안정하므로 제형의 안정성에는 문제가 없었다.The extract of the present invention was stable in all formulation test conditions and therefore had no problem in the stability of the formulation.

Claims (7)

산수국(Hydrangea serrata)의 물, 에탄올 또는 이들의 혼합용매로 추출된 추출물을 유효성분으로 함유하는 주름개선 및 피부 미백용 조성물.
A composition for improving wrinkles and skin whitening comprising Hydrangea serrata extract of water, ethanol or a mixed solvent thereof as an active ingredient.
삭제delete 제 1항에 있어서, 상기 조성물은 조성물 총 중량대비 0.001 내지 80중량% 포함하는 것을 특징으로 하는 주름개선 및 피부 미백용 조성물.
The composition for improving wrinkles and skin whitening according to claim 1, wherein the composition comprises 0.001 to 80% by weight based on the total weight of the composition.
제 1항에 있어서, 상기 조성물은 엘라스타아제(Elastase)를 저해함으로써 주름개선 효과를 나타내는 것을 특징으로 하는 주름개선 및 피부 미백용 조성물.
The composition according to claim 1, wherein the composition exhibits a wrinkle-reducing effect by inhibiting elastase.
제 1항에 있어서, 상기 조성물은 티로시나아제(Tyrosinase)를 저해함으로써 피부미백 효과를 나타내는 것을 특징으로 하는 주름개선 및 피부 미백용 조성물.
The composition according to claim 1, wherein the composition exhibits a skin whitening effect by inhibiting tyrosinase.
제 1항에 있어서, 상기 조성물은 정제, 과립제, 환제, 캡슐제, 액상형, 젤리 또는 껌으로 구성되는 군으로부터 선택된 하나 이상의 제형을 갖는 것으로서, 건강기능 식품용인 것을 특징으로 하는 주름개선 및 피부미백용 조성물.
The composition according to claim 1, wherein the composition has one or more formulations selected from the group consisting of tablets, granules, pills, capsules, liquids, jellies or gums, Composition.
제 1항에 있어서, 상기 조성물은 유연화장수, 영양 화장수, 영양 크림, 수분 크림, 스팟, 젤 또는 로션으로 구성된 군으로부터 선택된 하나 이상의 제형을 갖는 것으로서, 피부 외용제용인 것을 특징으로 하는 주름개선 및 피부미백용 조성물.The composition according to claim 1, wherein the composition has at least one formulation selected from the group consisting of softening water, nutritional lotion, nutritional cream, water cream, spot, gel or lotion, / RTI >
KR1020160062854A 2016-05-23 2016-05-23 Composition comprising for skin-whitening and anti-wrinkling extract of Rumex acetosella L. or extract of Hydrangea serrata KR101936294B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020160062854A KR101936294B1 (en) 2016-05-23 2016-05-23 Composition comprising for skin-whitening and anti-wrinkling extract of Rumex acetosella L. or extract of Hydrangea serrata

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020160062854A KR101936294B1 (en) 2016-05-23 2016-05-23 Composition comprising for skin-whitening and anti-wrinkling extract of Rumex acetosella L. or extract of Hydrangea serrata

Publications (2)

Publication Number Publication Date
KR20170132388A KR20170132388A (en) 2017-12-04
KR101936294B1 true KR101936294B1 (en) 2019-01-08

Family

ID=60921453

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020160062854A KR101936294B1 (en) 2016-05-23 2016-05-23 Composition comprising for skin-whitening and anti-wrinkling extract of Rumex acetosella L. or extract of Hydrangea serrata

Country Status (1)

Country Link
KR (1) KR101936294B1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20200098042A (en) 2019-02-11 2020-08-20 코스맥스바이오 주식회사 A composition for inhibiting fatty formation and reducing body fat comprising of hydrangenol as an active ingredient
KR20230064369A (en) 2021-11-03 2023-05-10 동의대학교 산학협력단 Composition for skin whitening and wrinkle improvement containing saussurea neoserrata extract

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101946526B1 (en) * 2017-12-19 2019-02-11 코스맥스바이오 주식회사 Composition of preventing or improving UV-induced skin damage comprising hydrangenol
KR102141039B1 (en) * 2017-12-20 2020-08-05 재단법인 홍천메디칼허브연구소 Compositions for preventing or treating Psoriasis comprising extract of Rumex acetosella
KR102313083B1 (en) * 2018-11-19 2021-10-18 제주대학교 산학협력단 An anti-oxidative composition comprising an extract of Hydrangea petiolaris or a fraction thereof as an active ingredient
KR102173731B1 (en) 2020-08-12 2020-11-03 계명대학교 산학협력단 Composition for Improving Wrinkle, Wound Healing, Cosmetic Surgery, Treating Hair Loss, or Stimulating Hair Growth Comprising Protein Hydrolysate of larva of Tenebrio molitor

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003246722A (en) 2002-02-25 2003-09-02 Kanebo Ltd Whitening cosmetic
KR100667448B1 (en) * 2005-09-01 2007-01-10 주식회사 쵸이스코스메틱 Cosmetic composition containing a gynostemma pentaphyllum makino extract
JP2011246353A (en) 2010-05-22 2011-12-08 Pola Chemical Industries Inc Skin external preparation

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003246722A (en) 2002-02-25 2003-09-02 Kanebo Ltd Whitening cosmetic
KR100667448B1 (en) * 2005-09-01 2007-01-10 주식회사 쵸이스코스메틱 Cosmetic composition containing a gynostemma pentaphyllum makino extract
JP2011246353A (en) 2010-05-22 2011-12-08 Pola Chemical Industries Inc Skin external preparation

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20200098042A (en) 2019-02-11 2020-08-20 코스맥스바이오 주식회사 A composition for inhibiting fatty formation and reducing body fat comprising of hydrangenol as an active ingredient
KR20230064369A (en) 2021-11-03 2023-05-10 동의대학교 산학협력단 Composition for skin whitening and wrinkle improvement containing saussurea neoserrata extract

Also Published As

Publication number Publication date
KR20170132388A (en) 2017-12-04

Similar Documents

Publication Publication Date Title
KR101936294B1 (en) Composition comprising for skin-whitening and anti-wrinkling extract of Rumex acetosella L. or extract of Hydrangea serrata
KR101902911B1 (en) Composition for improving human skin cell injury by UV-B comprising the extract of Hydrangea serrata
KR20090080153A (en) Composition for wrinkle-care and skin-whitening
KR102253095B1 (en) Cosmetic composition for improving acned skin, Manufacturing method thereof and functional cosmetics for improving acned skin containing the same
KR101292837B1 (en) Composition for skin wrinkle improvement comprising extracts of Junglans mandshurica MAXIM as an active ingredient
KR101182032B1 (en) Composition comprising the essential oil extract of Laminaria japonica showing anti-oxidant activity
KR20130010250A (en) Composition for skin wrinkle improvement comprising extracts of honeybush extract or its fermentation solution as an active ingredient
KR102236071B1 (en) Composition for Improving Skin Trouble Using an Extract of Centella asiatica or Paeonia lactiflora Cultured with Magma Seawater
KR20100121352A (en) A composition comprising complex crude drug extract for anti-aging and improvement of skin
KR101954275B1 (en) Cosmetic compositions containing complex extract of gold kiwi peel and dragon fruit peel, and method manufacturing the same
KR20140068679A (en) Composition comprising extracts of white tea for the care of skin wrinkle
KR101447007B1 (en) Composition for antiaging comprising the extract of Dipterocarpus obtusifolius Teijsm. Ex Miq. as an active ingredient
KR101182059B1 (en) Composition comprising the essential oil extract of hizikia fusiforme showing anti-oxidant activity
KR102370528B1 (en) Compositions containing Beta vulgaris fermentation extract
KR102471009B1 (en) Cosmetic composition containing Albiggia kalkora extract for skin whitening and improving wrinkles
KR102154139B1 (en) Composition comprising fermentation of sap of painted maple, cacao nibs extract and granat extract
KR102128168B1 (en) Composition comprising the extract of Lentinula edodes and Acer pictum subsp. mono leaf for antioxidant effect
KR101249034B1 (en) Composition for skin wrinkle improvement and whitening comprising extracts of Coriandum sativum. L as an active ingredient
CN113631227A (en) Antiaging agent, antioxidant, antiinflammatory agent, whitening agent, and cosmetic
KR102590758B1 (en) Antioxidant or anti-inflammatory composition comprising extract of bilberry containing anthocyanidin components
KR102401490B1 (en) Compositions containing Angelica gigas extract
KR102355138B1 (en) Composition for whitening or anti-wrinkle of the skin comprising fermentated ziziphus jujuba seed as effective component
KR102313083B1 (en) An anti-oxidative composition comprising an extract of Hydrangea petiolaris or a fraction thereof as an active ingredient
KR102014960B1 (en) Composition for anti oxidation containing extract of soybean root
KR102609952B1 (en) Ample type cosmetic composition improving skin elasticity, Manufacturing method of the same and Ample type comsmetics improving skin elasticity

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E902 Notification of reason for refusal
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant